Increased levels of Vdac1 have been shown to be associated with the progression of diseases involving cognitive impairment, such as Alzheimer’s disease and neonatal hypoxia–ischemia (Shoshan-Barmatz et al., 2010; Xue et al., 2021). Here, VDAC1 is linked to Alzheimer disease.